Testosterone patches and injections both raise low testosterone into the normal range, but they do so with meaningfully different hormone profiles, side-effect patterns, and day-to-day practicalities. Patches deliver a slow, steady stream of testosterone through the skin that roughly mimics the body’s natural daily rhythm, while standard injections (typically testosterone cypionate or enanthate given every one to two weeks) produce a sharp spike after the shot followed by a gradual decline. That difference in how the hormone enters your bloodstream ripples outward into everything from red blood cell counts to muscle gains to mood stability.
How Blood Levels Differ
The most fundamental distinction between patches and injections is the shape of the testosterone curve over time. A transdermal patch releases testosterone at a controlled rate, avoiding the liver’s first-pass metabolism and producing a pattern that loosely tracks the body’s own morning-high, evening-low rhythm.1PubMed. Transdermal testosterone delivery: testosterone patch and gel In a head-to-head comparison, patches kept total testosterone, bioavailable testosterone, and estradiol within normal ranges throughout the dosing period. Biweekly injections of testosterone enanthate, by contrast, pushed testosterone and estradiol to supraphysiological levels for several days after each shot before declining toward the low end before the next one.2The Journal of Clinical Endocrinology & Metabolism. Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men
That said, no exogenous testosterone product perfectly replicates the pattern seen in healthy younger men. A review of how various testosterone therapies interact with the body’s internal clock concluded that all replacement methods target a boost in average levels into the normal range and improve symptoms, but none truly mimic the natural diurnal variation.3Andrology. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age Patches come closer than intramuscular injections, but “closer” is not “identical.” Still, the flatter profile of a patch means you avoid the rollercoaster that many injection users describe: a few days of feeling energized and sharp right after their shot, followed by a slump as levels fall.
Muscle, Bone, and Body Composition
If your main goal is building lean mass or reversing muscle loss, the route of delivery matters more than you might expect. Because typical intramuscular injection doses are higher than transdermal doses, they produce greater musculoskeletal benefits.4American Journal of Physiology-Endocrinology and Metabolism. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men A systematic review and meta-analysis that separated outcomes by delivery route found that intramuscular testosterone was associated with roughly a 6% increase in fat-free mass and 10 to 13% increases in both upper- and lower-body strength, compared with about a 2% gain in fat-free mass and smaller strength gains with transdermal formulations. Transdermal testosterone produced no statistically meaningful improvement in lower-body strength at all.5Journal of Cachexia, Sarcopenia and Muscle. Muscular responses to testosterone replacement vary by administration route: a systematic review and meta‐analysis
Those differences are partly a dose effect. Injections tend to deliver more total testosterone per cycle than patches or gels, which drives bigger changes in muscle protein synthesis and bone mineral density. Whether that extra potency is a benefit or a risk depends on the individual. For an older man whose primary concern is preventing falls and fractures, the larger musculoskeletal effect of injections might be worth the trade-offs discussed below. For someone mainly looking to resolve fatigue and low libido, the more modest but steadier transdermal approach may be enough.
Red Blood Cell Counts and Polycythemia Risk
Every form of testosterone replacement raises your hematocrit, the proportion of your blood made up of red blood cells. That is not inherently dangerous in moderation, but when hematocrit climbs too high it thickens the blood and increases the risk of clots. A Bayesian network meta-analysis of randomized trials compared formulations head-to-head and found that intramuscular testosterone cypionate and enanthate raised mean hematocrit by about 4 percentage points, while patches raised it by about 1.4 points. Injections were the only formulation associated with a significantly higher hematocrit increase compared to patches.6PubMed. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials
Real-world data reinforce this pattern. In a study of transgender men on masculinizing hormone therapy, almost 90% of those who developed polycythemia-range hematocrit levels had been receiving testosterone cypionate, with other formulations rarely implicated.7Blood. The Prevalence and Management of Secondary Erythrocytosis in Transgender Individuals Undergoing Masculinizing Therapy This is likely driven by the supraphysiological peaks that follow each injection: bone marrow responds to those spikes by cranking out more red blood cells. The steadier levels from a patch simply do not trigger the same degree of erythropoietic stimulation. If you are already at risk for blood thickening, or if your doctor has flagged a rising hematocrit on routine bloodwork, patches carry a meaningful advantage here.
Cardiovascular Signals
Cardiovascular safety is one of the most debated aspects of testosterone therapy in general, and the delivery route adds another layer of complexity. A large observational study published in JAMA Internal Medicine compared outcomes among men initiating different testosterone formulations. Compared with gel users, men who started injections had a higher hazard of cardiovascular events including heart attack, unstable angina, and stroke, as well as higher rates of hospitalization and death. Patch users, by contrast, did not show increased hazards for cardiovascular events, hospitalization, death, or venous blood clots compared to gel users.8JAMA Internal Medicine. Comparative Safety of Testosterone Dosage Forms
This is observational data, so it does not prove that injections cause cardiovascular harm. Men who choose injections may differ in important ways from men who choose patches or gels, including baseline health, income, and frequency of medical follow-up. But the signal is consistent with the hematocrit data and the supraphysiological peaks associated with injections. At minimum, it is a reason to take regular monitoring seriously if you are on injectable testosterone, and it may tip the balance toward transdermal delivery for men with existing cardiovascular risk factors.
DHT and What It Means
Dihydrotestosterone, or DHT, is a more potent metabolite that testosterone gets converted into in certain tissues. It plays a role in hair loss, prostate growth, and skin oiliness. Interestingly, the route of testosterone delivery affects how much DHT your body produces, and not in the direction most people would guess. A systematic review and meta-analysis found that transdermal testosterone raised DHT levels about five-and-a-half-fold, while intramuscular testosterone raised them only about two-fold.9PubMed Central. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
The reason is that the skin itself is rich in the enzyme that converts testosterone to DHT. When testosterone crosses through the skin from a patch (or gel), more of it gets converted along the way than when it is deposited directly into muscle tissue and absorbed into the bloodstream. Whether this matters clinically is unclear. The same meta-analysis did not find that the higher DHT from transdermal delivery translated into worse prostate outcomes, and a head-to-head trial showed comparable prostate-specific antigen levels and prostate volumes between patch and injection users.10The Journal of Clinical Endocrinology & Metabolism. Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men But if you are prone to male-pattern hair loss or already monitoring prostate health, the DHT difference is worth a conversation with your prescriber.
Mood, Sexual Function, and Day-to-Day Well-Being
For many men, the reason they seek testosterone replacement in the first place is how they feel: low energy, dampened libido, brain fog, irritability. On these softer endpoints, the evidence suggests both patches and injections help, but the quality of that help differs. In the head-to-head trial discussed earlier, both transdermal patches and biweekly injections maintained sexual function and mood at levels comparable to prior treatment, with no significant difference between routes.11The Journal of Clinical Endocrinology & Metabolism. Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men
However, the steady hormone levels from transdermal delivery appear to produce more stable moods with fewer swings, while injections (particularly shorter-acting cypionate and enanthate given at longer intervals) are associated with fluctuations in mood, sexual desire, and energy that track the peak-and-trough pattern.12PubMed Central. Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations Research on transgender men undergoing masculinizing therapy found that patches and gels maintained consistent blood testosterone levels and resulted in stable emotional states with fewer mood swings, though mild mood changes could occur during the initial adaptation period.13European Psychiatry. Comprehensive Analysis of Hormone Formulations and Emotional Effects in Transgender Men Undergoing Hormone Replacement Therapy If emotional steadiness matters to you, a patch has a structural advantage. If you are someone who does well with the “on” feeling after an injection and does not mind a dip before the next one, the pattern might not bother you.
Fertility Considerations
All exogenous testosterone suppresses the hormones that drive sperm production, but the degree of suppression depends on the delivery method. A review comparing longer-acting and shorter-acting formulations found that long-acting injectable testosterone decreased follicle-stimulating hormone (FSH) by about 86% and luteinizing hormone (LH) by about 72%. Intermediate-acting daily formulations like gels and patches suppressed FSH by about 60% and LH by about 59%.14PubMed. The Effect of Longer-Acting vs Shorter-Acting Testosterone Therapy on Follicle Stimulating Hormone and Luteinizing Hormone
This means that if preserving fertility is a concern, patches are somewhat less damaging to the reproductive hormonal axis than long-acting injections, though neither route is safe to use as a standalone approach if you are actively trying to conceive. Any man on testosterone therapy who wants to maintain or restore fertility should discuss this explicitly with his doctor, because the suppression from both routes can persist for months after stopping.
Practical Annoyances and Lifestyle Fit
Beyond the pharmacology, the daily lived experience of each method drives a lot of real-world decisions. Patches have a well-known problem: skin irritation. A substantial number of users experience redness, itching, or rash at the application site, and sweating during warmer months can cause the patch to peel off or adhere poorly.15PubMed Central. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option You need to rotate application sites, avoid showering or swimming shortly after applying, and some men simply find the daily ritual tiresome. The upside is that there is no needle involved and no need for a clinic visit.
Injections bring their own hassles. Traditional intramuscular shots use a larger needle pushed into the thigh or gluteal muscle, which many patients find uncomfortable enough that they need a healthcare provider to do it. Self-injection is possible but can be anxiety-provoking, particularly at first. Injection-site soreness, occasional bruising, and very rarely a localized infection round out the list of nuisances. On the positive side, a biweekly injection takes about two minutes, and then you do not think about testosterone again for days.
Transfer risk is another practical concern. A comparison study found large differences in how much testosterone can be transferred from the application site of a patch versus a gel, with gels posing the greater transfer risk through skin-to-skin contact.16The Journal of Sexual Medicine. Transfer of Transdermally Applied Testosterone to Clothing: A Comparison of a Testosterone Patch Versus a Testosterone Gel Patches, because they cover the application site, reduce this risk substantially compared to gels, though covering the gel area with clothing also helps. Injections sidestep transfer concerns entirely since the testosterone goes directly into tissue.
Cost enters the equation, too. Injectable testosterone cypionate (typically sold as Depo-Testosterone or its generic equivalents) is generally the cheapest option on the market, while patches tend to carry a higher price, particularly for brand-name versions. Insurance coverage varies, but the raw drug cost of generic injectable testosterone is consistently lower.
The Subcutaneous Injection Middle Ground
A relatively newer option blurs the line between traditional injections and the steadier profiles of transdermal delivery. Subcutaneous injections use a smaller needle inserted just under the skin rather than deep into muscle. The testosterone exposure from subcutaneous and intramuscular routes is comparable, but patients report significantly less preinjection anxiety, less pain during the shot, and less soreness afterward.17PubMed. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study A subcutaneous autoinjector designed to deliver testosterone enanthate weekly also produced a lower peak-to-trough ratio than traditional intramuscular cypionate, which translated into lower post-treatment estradiol and hematocrit levels without sacrificing overall testosterone levels.18PubMed. Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate
Self-administration is easier with the subcutaneous route because there is no risk of hitting the sciatic nerve, the needles are thinner, and the injection can be done with one hand into the abdomen or thigh. Side effects are generally minor: small painless nodules that resolve in a day or two, occasional bruising, and rare localized inflammation.19PubMed Central. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option For men who want the cost advantage and potency of injectable testosterone but dislike the peaks-and-troughs cycle and the discomfort of a deep intramuscular needle, the subcutaneous route is worth discussing with a prescriber. Evidence is still more limited than for traditional intramuscular injections, but what exists looks promising.
Patient Satisfaction and Long-Term Adherence
Sticking with testosterone therapy over months and years is where the rubber meets the road, and satisfaction patterns differ by formulation. Research comparing patient preferences found that long-acting intramuscular injections (like testosterone undecanoate, given every 10 to 14 weeks) earned the highest satisfaction scores because of their low injection frequency, stable levels, and the fact that patients were not confronted with their treatment daily. Daily gels were seen as easy to use but brought the annoyance of constant application and the worry of reduced compliance. Short-acting injections given every one to two weeks received the lowest satisfaction ratings, primarily because of the large fluctuations in mood, sexual desire, and energy.20PubMed Central. Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations
Patches occupy an interesting middle ground in adherence. They avoid needles entirely, and brand-name patches have been reported to bring up to 92% of patients into the normal testosterone range. But the skin irritation issue is a genuine dropout driver. Many men who start on patches eventually switch to gels or injections simply because the redness and itching become intolerable. If your skin tolerates patches well, they offer one of the most physiologically natural replacement patterns available. If it does not, the daily frustration tends to outweigh the pharmacokinetic advantages.
How Patch Technology Has Evolved
Early testosterone patches were designed for scrotal application, which took advantage of the thinner skin in that area for better absorption. Nonscrotal patches followed and delivered far more testosterone per day by using permeation-enhancing technology. Laboratory studies comparing the two designs found that a nonscrotal system delivered roughly four times the daily dose and achieved about four times the peak concentration compared to a scrotal patch.21PubMed. Transdermal testosterone delivery: comparison between scrotal and nonscrotal delivery systems Modern patches use matrix-type designs where testosterone is embedded throughout an adhesive layer, allowing it to release steadily over 24 hours. Further refinements have improved the release rate significantly over earlier generations.22PubMed. In vitro and in vivo evaluation of a novel nonscrotal matrix-type transdermal delivery system of testosterone The scrotal patch has largely disappeared from the market, but understanding the evolution helps explain why modern nonscrotal patches work as well as they do and why older studies of scrotal patches should not be used to judge current products.
Even with these improvements, the total amount of testosterone a patch can push through the skin in a day has a ceiling imposed by skin permeability. This is why transdermal doses are inherently lower than typical injection doses, which in turn explains the smaller musculoskeletal effects discussed earlier. It is a physical limitation of the delivery method, not a flaw in any particular product design.
Choosing Between Them in Gender-Affirming Care
Transgender men and transmasculine individuals face largely the same pharmacological trade-offs as cisgender men with hypogonadism, but with a few additional considerations. Masculinizing hormone therapy often involves higher target testosterone levels and longer treatment durations, which amplifies the differences between routes. The greater suppression of FSH and LH from long-acting injectables may be less of a concern for transgender men who do not plan on biological fertility, while the mood stability associated with patches and gels can matter more in a population already navigating significant psychosocial stressors.23European Psychiatry. Comprehensive Analysis of Hormone Formulations and Emotional Effects in Transgender Men Undergoing Hormone Replacement Therapy
In practice, injectable testosterone cypionate dominates gender-affirming care in many countries because of its low cost, effectiveness, and familiarity among prescribers. Subcutaneous self-injection has become increasingly popular in this population for its combination of affordability and tolerability. Patches remain a small fraction of prescriptions, in part because the doses achievable through skin delivery may not be sufficient for faster masculinization, and in part because skin irritation limits long-term use. For transgender men who prioritize emotional stability and want to avoid needles, though, patches remain a viable and sometimes underutilized option.